cgp 12177 has been researched along with Lung Neoplasms in 2 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qing, F | 2 |
| Rhodes, CG | 2 |
| Hayes, MJ | 2 |
| Krausz, T | 2 |
| Fountain, SW | 2 |
| Jones, T | 2 |
| Hughes, JM | 2 |
| Burke, MM | 1 |
2 other studies available for cgp 12177 and Lung Neoplasms
| Article | Year |
|---|---|
In vivo quantification of human pulmonary beta-adrenoceptor density using PET: comparison with in vitro radioligand binding.
Topics: Adrenergic beta-Antagonists; Carbon Radioisotopes; Carcinoma, Bronchogenic; Humans; Image Processing | 1996 |
Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Volume; Carcinoma; Cell Count; Humans; Lung; Lung Ne | 1996 |